These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 4626749
21. Immunosuppressive therapy in management of non-malignant disease. Fennelly JJ, Fitzgerald MX, Fitzgerald O. J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154 [No Abstract] [Full Text] [Related]
22. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis]. Heine KM, Klatt R, Stobbe H, Apostoloff E, Jendrusch C. Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:152-4. PubMed ID: 5402572 [No Abstract] [Full Text] [Related]
23. The clinical use of immunosuppression. Watson DW, Johnson AG. Med Clin North Am; 1969 Nov 01; 53(6):1225-41. PubMed ID: 4902918 [No Abstract] [Full Text] [Related]
24. [Immunosuppressive therapy in autoimmune diseases]. Schwenke H, Helbig W, Müldner J. Dtsch Gesundheitsw; 1971 Mar 25; 26(13):573-9. PubMed ID: 5576681 [No Abstract] [Full Text] [Related]
25. [Our experiences with Imuran treatment]. Golacka K, Tarka Z. Pol Tyg Lek; 1971 Mar 08; 26(10):345-6. PubMed ID: 5550676 [No Abstract] [Full Text] [Related]
26. [Immunosuppressive therapy]. Melli G. Recenti Prog Med; 1970 Jan 08; 48(1):1-18. PubMed ID: 4910156 [No Abstract] [Full Text] [Related]
27. [Immunosuppressive therapy of autoimmune hemolytic anemias. (Preliminary report)]. Nelius D, Stieglitz R, Baer I. Allerg Asthma (Leipz); 1969 Jan 08; 15(4):268-71. PubMed ID: 5400711 [No Abstract] [Full Text] [Related]
28. [What is certain in the treatment with immunosuppressive agents?]. Malchow H. Internist (Berl); 1971 Dec 08; 12(12):504-12. PubMed ID: 4944681 [No Abstract] [Full Text] [Related]
29. [Results of immunosuppressive treatment of visceral lupus erythematosus]. Japa J, Kardaszewicz E. Pol Tyg Lek; 1969 Oct 06; 24(40):1534-6. PubMed ID: 5365671 [No Abstract] [Full Text] [Related]
30. Selected problems in immunosuppressive therapy. Rondio H. Mater Med Pol; 1974 Oct 06; 6(1):34-40. PubMed ID: 4613962 [No Abstract] [Full Text] [Related]
31. [Immunodepressive agents in hematology]. Sanchez-Fayos J, Outeiriño J, Serrano J, Calabuig MT, Paniagua G. Cah Med; 1970 May 15; 11(5):433-43. PubMed ID: 5463876 [No Abstract] [Full Text] [Related]
32. [Auto-immune diseases and immunodepressive therapy. II. Current clinical indications]. Delespesse G, Kennes B, Duchateau J. Acta Clin Belg; 1974 May 15; 29(6):413-23. PubMed ID: 4155218 [No Abstract] [Full Text] [Related]
37. [Theoretical basis of immunosuppression in autoimmune diseases]. Haustein UF. Dermatol Monatsschr; 1972 Aug 31; 158(8):547-71. PubMed ID: 4404036 [No Abstract] [Full Text] [Related]
38. [Immunosuppressive therapy in immuno-hematologic diseases]. Miescher PA. Verh Dtsch Ges Inn Med; 1972 Aug 31; 78():764-5. PubMed ID: 4665749 [No Abstract] [Full Text] [Related]
39. Drug therapy: immunosuppressive agents (second of two parts). Kaplan SR, Calabresi P. N Engl J Med; 1973 Dec 06; 289(23):1234-6. PubMed ID: 4594161 [No Abstract] [Full Text] [Related]
40. Rituximab in autoimmune pancytopenia: a case report and review of literature. Reale LD, Besa EC. Ann Hematol; 2007 Dec 06; 86(12):913-6. PubMed ID: 17541587 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]